chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Vaccination site pain
Clinical narrative: Sore left arm at injection site; Intense chills; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 25Apr2021 at 13:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 03Apr2021 at 14:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 26Apr2021 at 05:00, the patient experienced sore left arm at injection site, intense chills, headache and fatigue. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore left arm at injection site, intense chills, headache and fatigue was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Dizziness, Headache, Nasal congestion, Oropharyngeal pain
Clinical narrative: Sore throat; Swollen throat; Stuffy head; Stuffy nose; Headache; Arm pain; Dizziness; Feeling of being dehydrated; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Apr2021 at 12:15 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 25Apr2021 at 14:00, the patient experienced sore throat, swollen throat, stuffy head, stuffy nose, headache, arm pain, dizziness and feeling of being dehydrated. The events did not result in doctor or other healthcare professional office/clinic visit/emergency visit. No therapeutic measures were taken as a result of events. Since the vaccination, the patient had been tested for COVID-19. On an unknown date, the patient underwent SARS-CoV-2 (nasal swab) and the result was negative. The clinical outcome of the events sore throat, swollen throat, stuffy head, stuffy nose, headache, arm pain, dizziness and feeling of being dehydrated was unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pharyngeal oedema, SARS-CoV-2 test, Upper respiratory tract congestion
Clinical narrative: Sore throat; Swollen throat; Stuffy head; Stuffy nose; Headache; Arm pain; Dizziness; Feeling of being dehydrated; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Apr2021 at 12:15 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 25Apr2021 at 14:00, the patient experienced sore throat, swollen throat, stuffy head, stuffy nose, headache, arm pain, dizziness and feeling of being dehydrated. The events did not result in doctor or other healthcare professional office/clinic visit/emergency visit. No therapeutic measures were taken as a result of events. Since the vaccination, the patient had been tested for COVID-19. On an unknown date, the patient underwent SARS-CoV-2 (nasal swab) and the result was negative. The clinical outcome of the events sore throat, swollen throat, stuffy head, stuffy nose, headache, arm pain, dizziness and feeling of being dehydrated was unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Ear pain, Tinnitus
Clinical narrative: Pressure in right ear developed 5 daysafter vaccination; Pain in right ear developed 5 days after vaccination; Tinnitus developed in both ears 36 hours after vaccination.; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EE 8730) via an unspecified route of administration in the right arm on 31Mar2021 at 12:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa and dairy. Concomitant medication taken within two weeks of vaccination was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 05:00, 36 hours after vaccination, the patient experienced tinnitus developing in both ears. On 05Apr2021, 5 days after vaccination, patient developed pain and pressure in right ear. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of tinnitus, pain in ear and pressure in ear. The patient saw an ENT/Audiologist, 19 days after vaccination and received a week-long series of steroids (MANUFACTURER UNKNOWN) and fluticasone propionate (FLONASE). Pain in my right ear decreased during the steroid series, but has returned since completing the steroid prescription. No change in tinnitus severity with the steroid and Flonase. The tinnitus is continuous and increases in severity with increased sodium intake or lack of sleep. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tinnitus developed in both ears, pressure in right ear and pain in right ear was not recovered at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Nausea, Peripheral swelling, Rash
Clinical narrative: Hives/itchy rash and swelling at injection site, down left arm, left ankle/leg, right ankle/leg, and right upper arm; Hives/itchy rash and swelling at injection site, down left arm, left ankle/leg, right ankle/leg, and right upper arm; Hives/itchy rash and swelling at injection site, down left arm, left ankle/leg, right ankle/leg, and right upper arm; Hives/itchy rash and swelling at injection site, down left arm, left ankle/leg, right ankle/leg, and right upper arm; Hives/itchy rash and swelling at injection site, down left arm, left ankle/leg, right ankle/leg, and right upper arm; Nausea; Diarrhea; Weakness (difficultyclimbing stairs); This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 11:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ethinylestradiol/norethisterone (ALYACEN) for an unknown indication from an unknown date and unknown if ongoing. On 03Apr2021, the patient experienced hives/itchy rash and swelling at injection site, down left arm, left ankle/leg, right ankle/leg, right upper arm, nausea and diarrhea lasting 6 days and weakness (difficulty climbing stairs). The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event rash and included treatment with prednisone (MANUFACTURER UNKNOWN) and hydrocortisone (MANUFACTURER UNKNOWN) cream. Since the vaccination, the patient had been tested for COVID-19. On 06Apr2021, the patient underwent SARS CoV-2 test via nasal swab and the result was negative. The clinical outcome of the events hives/itchy rash, swelling at injection site, down left arm, left ankle/leg, right ankle/leg, right upper arm, nausea diarrhea and weakness was resolved on an unknown date in Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vaccination site rash, Vaccination site swelling, Vaccination site urticaria
Clinical narrative: Hives/itchy rash and swelling at injection site, down left arm, left ankle/leg, right ankle/leg, and right upper arm; Hives/itchy rash and swelling at injection site, down left arm, left ankle/leg, right ankle/leg, and right upper arm; Hives/itchy rash and swelling at injection site, down left arm, left ankle/leg, right ankle/leg, and right upper arm; Hives/itchy rash and swelling at injection site, down left arm, left ankle/leg, right ankle/leg, and right upper arm; Hives/itchy rash and swelling at injection site, down left arm, left ankle/leg, right ankle/leg, and right upper arm; Nausea; Diarrhea; Weakness (difficultyclimbing stairs); This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 11:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ethinylestradiol/norethisterone (ALYACEN) for an unknown indication from an unknown date and unknown if ongoing. On 03Apr2021, the patient experienced hives/itchy rash and swelling at injection site, down left arm, left ankle/leg, right ankle/leg, right upper arm, nausea and diarrhea lasting 6 days and weakness (difficulty climbing stairs). The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event rash and included treatment with prednisone (MANUFACTURER UNKNOWN) and hydrocortisone (MANUFACTURER UNKNOWN) cream. Since the vaccination, the patient had been tested for COVID-19. On 06Apr2021, the patient underwent SARS CoV-2 test via nasal swab and the result was negative. The clinical outcome of the events hives/itchy rash, swelling at injection site, down left arm, left ankle/leg, right ankle/leg, right upper arm, nausea diarrhea and weakness was resolved on an unknown date in Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Pyrexia
Clinical narrative: Muscle Pain; Joint Pain; Feverish; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration on an unknown date (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On an unknown date the patient experienced muscle pain, joint pain and feverish. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of the event. The clinical outcome of the events muscle pain, joint pain and feverish was recovered on an unknown date at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Gait disturbance, Pain in extremity, Pollakiuria
Clinical narrative: Felt like I was developing fever but head was cool to touch; Made it difficult to raise right leg or push leg behind butt, get up out of chair or bed, run, go up/down stairs, get into and out of car/ Could only jog at half of normal pace in 2 races 4/24, 4/25 after being able to run normally 4/22; Urinating much more frequently up to every half hour/hourly from 4/23 to 4/25; Also chills on 4/14, less severe chills on 4/23; Arm soreness from 4/14 to 4/17/Soreness, pain at or near right groin area/thigh area (but not right buttock) experienced on waking up on Friday,April 23.; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 13Apr2021 at 17:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 23Mar2021 at 16:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 14Apr2021, the patient experienced arm soreness till 17Apr2021 and chills; less severe chills on 23Apr2021. On 23Apr2021 at 06:00, the patient had soreness, pain at or near right groin area/thigh area (but not right buttock) experienced on waking up, made it difficult to raise right leg or push leg behind butt, get up out of chair or bed, run, go up/down stairs, get into and out of car, felt like he was developing fever but head was cool to touch, urinating much more frequently up to every half hour/hourly from 23Apr2021 to 24Apr2021. He could only jog at half of normal pace in 2 races on 24Apr2021 and 25Apr2021, after being able to run normally on 22Apr2021. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event soreness was recovered on 17Apr2021. The clinical outcome of the events soreness, pain at or near right groin area/thigh area (but not right buttock) experienced on waking up, made it difficult to raise right leg or push leg behind butt, get up out of chair or bed, run, go up/down stairs, get into and out of car, felt like he was developing fever but head was cool to touch, urinating much more frequently and could only jog at half of normal pace in 2 races was recovering at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchitis, Illness, Malaise, Sinusitis
Clinical narrative: SICK; she has bronchitis and a sinus infection; she has bronchitis and a sinus infection; she is not feeling well; This is a spontaneous report from a contactable consumer or other non hcp.    A 74-years-old female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection), dose 1 via an unspecified route of administration on 06Apr2021 (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunisation.  The patient medical history was not reported. The patient's concomitant medications were not reported.  It was reported that, 74-year-old caller mentioned she received the first dose of the Pfizer-BioNTech COVID-19 vaccine on 6April 012. She explained she is scheduled to receive the second dose tomorrow, but she is "sick". She specified she has no fever and has either a "sinus infection" or "bronchitis". She asked if she should get the second dose as scheduled. Patient received the first dose of the vaccine on 06Apr2021 and is scheduled to get her second dose tomorrow, 27Apr2021 but is not feeling well and likened her symptoms to that of bronchitis. She mentioned that the vaccination card she has expires on 30Jul2021 so she would like to know if it would be okay to receive the second dose a week later than the scheduled appointment of three weeks. The outcome of the events was unknown on an unspecified date.  No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Parosmia
Clinical narrative: Smelling cigarette smoke; This is a spontaneous report from a contactable consumer. A 50-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0153) via an unspecified route of administration in the arm left on 21Apr2021 at 18:00 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 in january and got fully recovered by 14 february. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included simvastatin (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN) both for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within 4 weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (COMIRNATY; Lot Number: er8732) via an unspecified route of administration on 24Mar2021 at 16:00 as a single dose for COVID-19 immunisation. On 23Apr2021 at 18:00, 48 hours after the vaccination, the patient constantly experienced smelling cigarette smoke regardless of where the patient was at. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event smelling cigarette smoke was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Eye pain, Eye swelling, Vision blurred
Clinical narrative: Within fifteen minutes my vision became blurry./vision remains slightly blurry.; Was too weak to stand.; Over the course of the following days, my left eye area has become swollen; Over the course of the following days, my left eye area has become swollen and painful; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 24Apr2021 at 09:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included aripiprazole (ABILIFY) and fluoxetine hydrochloride (PROZAC); for unknown indication from unknown start date and unknown if ongoing. On 24Apr2021 at 10:00 within fifteen minutes the patient's vision became blurry and also felt too weak to stand. This reaction faded within an hour. On an unknown date in Apr2021, over the course of the following days the patient's left eye area had become swollen, painful and vision remained slightly blurry. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events too weak to stand was recovered with sequelae within an hour on 24Apr2021 at 11:00; while that of the events left eye area had become swollen and painful was recovered with sequelae on an unknown date in Apr2021. The clinical outcome of the event vision became blurry was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in extremity, Sensory loss
Clinical narrative: Right arm (vaccinated arm) has been in pain; Arm goes numb; Lose sensation on hand; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 30Mar2021 at 16:45 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On 30Mar2021 at 16:45, the patient experienced right arm (vaccinated arm) been in pain, arm goes numb and lose sensation on hand. It was reported that, patient was unable to lift it even half way up without feeling pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event right arm (vaccinated arm) been in pain, arm goes numb and lose sensation on hand were recovering at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal distension, Abdominal pain, Abdominal pain upper
Clinical narrative: Had bloating; Severe stomach/abdominal pain; Severe stomach/abdominal pain; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 24Apr2021 at 14:00 (at the age of 30-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 03Apr2021 at 13:30 (at the age of 30-year-old), as a single dose for COVID-19 immunisation. On 26Apr2021 at 04:00, the patient experienced bloating and severe stomach/abdominal pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events bloating and severe stomach/abdominal pain was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Axillary pain
Clinical narrative: Feeling pain under my left armpit; Possibly feeling a lump as well; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 46-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Apr2021 at 10:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included Thyroid (Hashimoto's) and allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine sodium (SYNTHROID) for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took procaine (NOVACAINE) and experienced drug allergy. On 26Apr2021 at 07:00, the patient felt pain under her left armpit, possibly felt a lump as well. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/ department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event felt pain under left armpit and possibly felt a lump as well was not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: Severe back pain; Joint pain; Fever; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 23Apr2021 at 11:30(at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021 at 13:00, the patient experienced severe back pain, joint pain and fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had taken test for COVID-19. On 26Apr2021, the patient underwent nasal swab test and the result was pending. The clinical outcome of the events severe back pain, joint pain and fever were recovering at this time of report.  No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Fatigue, Myalgia, Oropharyngeal pain
Clinical narrative: Sore throat; Weakness; Sore muscles in neck and shoulder; Loss of appetite; Exhaustion; Runny nose; Heart palpitations; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 14Apr2021 at 09:30 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, and too many allergies which were not specified. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included levothyroxine, liothyronine (NP THYROID), estradiol (ESTROGEN) and curcumin (MANUFACTURER UNKNOWN); all from unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 24Mar2021 at 09:30 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021, the patient experienced sore throat, weakness, sore muscles in neck and shoulders, loss of appetite, exhaustion, runny nose, heart palpitations. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore throat, weakness, sore muscles in neck and shoulders, loss of appetite, exhaustion, runny nose, heart palpitations was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Rhinorrhoea
Clinical narrative: Sore throat; Weakness; Sore muscles in neck and shoulder; Loss of appetite; Exhaustion; Runny nose; Heart palpitations; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 14Apr2021 at 09:30 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, and too many allergies which were not specified. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included levothyroxine, liothyronine (NP THYROID), estradiol (ESTROGEN) and curcumin (MANUFACTURER UNKNOWN); all from unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 24Mar2021 at 09:30 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021, the patient experienced sore throat, weakness, sore muscles in neck and shoulders, loss of appetite, exhaustion, runny nose, heart palpitations. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore throat, weakness, sore muscles in neck and shoulders, loss of appetite, exhaustion, runny nose, heart palpitations was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Pain
Clinical narrative: Chills with teeth chatter; Severe joint aches; All over body aches; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via intramuscular route of administration in the left arm on 22Apr2021 at 11:15 (at the age of 48-year-old), as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via intramuscular route of administration in the left arm on 31Mar2021 at 11:15 (at the age of 48-year-old), as a single dose for COVID-19 immunisation. On 23Apr2021 at 02:00, the patient experienced chills with teeth chatter, severe joint aches, all over body aches and extreme fatigue. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills with teeth chatter, severe joint aches, all over body aches and extreme fatigue was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Muscle spasms, Pain
Clinical narrative: Headache,; Chills; Body ache; Muscle cramps; Pain; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Apr2021 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on an unknown date in 09Apr2021 at 17.45 hours (at the age of 39-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 23:00, the patient experienced headache, chills, body ache, muscle cramps and pain. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the event headache, chills, bodyache, muscle cramps and pain were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Nausea, Vomiting
Clinical narrative: Nausea; Vomiting; Extreme pain in armpit; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8735) via an unspecified route of administration in the right arm on 22Apr2021 at 14:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medications within two weeks of vaccination. On 23Apr2021, the patient experienced nausea, vomiting and extreme pain in armpit. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, vomiting and extreme pain in armpit was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Nausea, Pain in extremity
Clinical narrative: Nausea; Arm, elbow and hand pain at night; Arm, elbow and hand pain at night; Pain in armpit; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the right arm on 22Apr2021 at 14:00 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 23Apr2021, the patient experienced nausea and even arm, elbow and hand pain at night. On 23Apr2021, the patient also experienced pain in armpit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, arm, elbow and hand pain at night and pain in armpit were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Neck pain
Clinical narrative: Severe ear pain in my right ear; Some pain in the neck directly underneath my right ear; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 15:15 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 31Mar2021 at 21:00 about 5 - 6 hours after being vaccinated in left arm, the patient experienced severe ear pain in right ear and some pain in the neck directly underneath right ear. It was reported that ear pain took 3 weeks to subside and it was undoubtedly a direct result of the vaccine. The patient had never experienced an earache in life prior to being vaccinated. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe ear pain in right ear was recovered on an unknown date in Apr2021 and some pain in the neck directly underneath right ear was recovered on an unknown date in 2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Pain, Pyrexia
Clinical narrative: Fever spikes up to 102; Crushing headaches; Soreness at injection site; Soreness radiating through shoulder and underarm; Extreme fatigue; Significant body aches; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 20Apr2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 01Apr2021 at 09:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021, the patient experienced fever which spiked up to 102 (unspecified units), crushing headaches, soreness at injection site and radiating through shoulder and underarm, extreme fatigue and significant body aches; all these occurred post second dose. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with ibuprofen (ADVIL). The clinical outcome of the events fever up to 102 (unspecified units), crushing headaches, soreness at injection site and radiating through shoulder and underarm, extreme fatigue and significant body aches were recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Fever spikes up to 102; Crushing headaches; Soreness at injection site; Soreness radiating through shoulder and underarm; Extreme fatigue; Significant body aches; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 20Apr2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 01Apr2021 at 09:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021, the patient experienced fever which spiked up to 102 (unspecified units), crushing headaches, soreness at injection site and radiating through shoulder and underarm, extreme fatigue and significant body aches; all these occurred post second dose. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with ibuprofen (ADVIL). The clinical outcome of the events fever up to 102 (unspecified units), crushing headaches, soreness at injection site and radiating through shoulder and underarm, extreme fatigue and significant body aches were recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Lymphadenopathy
Clinical narrative: Left Breast Pain; swollen Lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 12Apr2021 at 11:15 as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHYROID) started on an unknown date for unknown indication and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 22Apr2021 at 13:00 the patient experienced left breast pain with swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left breast pain with swollen lymph nodes were not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Dysgeusia
Clinical narrative: Certain things taste off since vaccine/  ''I''ve eaten chicken 3 times since vaccine and each time tastes very off; Chicken tastes chemical and metallic sort of/ Certain fruits and veggies taste like dirt; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 16Apr2021 at 11:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included herniated disc L4-L5, bulged discs L1- L2, L2-L3, L3-L4, asthma, migraines. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), paracetamol (ACETAMINOPHEN), dexlansoprazole (DEXILANT), cannabis sativa (CBD/THC) and colla (MANUFACTURER UNKNOWN), all for an unknown indication from an unknown dates and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received sumatriptan (IMITREX), rizatriptan benzoate (MAXALT), naratriptan hydrochloride (AMERGE), tramadol hydrochloride (ULTRAM), caffeine/ergotamine (CAFERGOT) and butalbital/caffeine; paracetamol (ESGIC PLUS), for unknown indication from an unknown date and experienced drug allergy. On 20Apr2021 at 06:30, the patient experienced certain things tasted off since vaccine. Chicken tasted chemical and metallic sort of, certain fruits and veggies tasted like dirt. The patient could eat chicken soup and everything else tasted fine except the chunks of chicken. She had eaten chicken 3 times since vaccine and each time tasted very off. Different brands, from different sources, cooked by different people of the fruits and veggies that patient ate or smoothies she drank, since the vaccine, some of had tasted just like dirt mainly leafy greens and green juice blends. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of reported events. The clinical outcome of the events certain things tasted off since vaccine, chicken tasted chemical and metallic sort of and certain fruits and veggies tasted like dirt, she had eaten chicken 3 times since vaccine and each time tasted very off was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.